세계의 체외막산소공급(ECMO) 기계 시장 : 유형별, 구성요소별, 용도별 - 기회 분석 및 산업 예측(2024-2033년)

Extracorporeal Membrane Oxygenation Machine Market By Type , By Components By Application : Global Opportunity Analysis and Industry Forecast, 2024-2033

US $ 4,425 ￦ 6,279,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 7,412 ￦ 10,518,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

체외막산소공급(ECMO) 기계 시장은 2023년 5억 420만 달러로 평가되었고, 2024년부터 2033년까지 연평균 4.6% 성장하여 2033년에는 7억 9,370만 달러에 달할 것으로 예측됩니다.

체외막산소공급(ECMO) 기계는 이산화탄소 제거를 도와 산소가 풍부한 혈액을 체내로 되돌려주는 의료기기입니다. ECMO는 심장 및 폐 기능 장애를 앓고 있는 환자를 치료하기 위한 생명 유지 장치로, 혈액을 인공 폐(막형 산소 공급 장치)를 통해 혈액을 혈류로 되돌려 순환시키는 방식으로 작동합니다. 이 과정을 통해 혈액에 산소를 공급하고 이산화탄소를 제거하여 인간의 폐와 심장의 기능을 효과적으로 모방할 수 있습니다.

체외막산소공급장치(ECMO) 시장의 세계 성장은 심부전 및 심인성 쇼크와 같은 호흡기 및 심장 질환의 심각한 유병률 증가가 주요 요인으로 작용하고 있습니다. 영국 통계청의 추산에 따르면, 약 660만 명이 심혈관 또는 호흡기 질환을 앓고 있는 것으로 나타났습니다. 이 중 350만 명이 심혈관계 질환, 370만 명이 호흡기 질환을 앓고 있는 것으로 보고되고 있습니다. 또한, 의료진의 인식 개선과 의료 교육의 발전은 ECMO의 보급을 촉진하고 있습니다. 체외생명유지장치(ELSO) 레지스트리의 2023년 6월 평가에 따르면, 2020년 151,683명의 환자에게 에크모가 사용되었습니다. 이 중 75,735명이 성인, 30,743명이 소아, 45,205명이 신생아였습니다. 또한 노인 인구의 급격한 증가도 시장 성장에 크게 기여하고 있습니다. 이는 노인은 기능 장애로 인해 만성 질환과 장기 부전에 걸리기 쉽고 일상 생활 수행 능력이 제한되어 ECMO에 대한 수요가 증가하고 있다는 사실에 기인합니다. 세계보건기구(WHO)에 따르면 2019년 60세 이상 노인 인구는 10억 명에 달했습니다. 이 숫자는 2030년에는 14억 명, 2050년에는 21억 명으로 증가할 것으로 추정되며, 시장 성장에 크게 기여할 가능성이 높습니다. 그러나 ECMO 시스템의 초기 투자 및 유지 보수 비용과 시스템 운영 숙련자 부족이 시장 성장을 방해하고 있습니다. 또한, 많은 국가에서 인구의 요구를 충족시킬 수 있는 적절한 의료 시설이 부족하고 접근성이 제한되어 있는 것도 시장 성장의 주요 저해요인으로 작용하고 있습니다. 반대로, 더 작고 효율적인 시스템을 포함한 ECMO 기술의 지속적인 개선과 중증 환자를 위한 의료 인프라의 설치 및 개발에 대한 정부의 자금 지원 및 지원 증가는 예측 기간 동안 시장 확대에 유리한 기회를 제공할 것으로 예상됩니다.

체외막산소공급장치(ECMO) 시장은 유형, 구성요소, 용도, 지역으로 분류됩니다. 유형에 따라 시장은 정맥-동맥, 정맥-동맥, 동맥-동맥으로 분류됩니다. 구성 요소별로는 펌프, 산소 공급기, 컨트롤러, 기타로 분류됩니다. 용도별로는 성인, 소아, 신생아로 분류됩니다. 지역별로는 북미, 유럽, 아시아태평양, LAMEA로 분석됩니다.

주요 조사 결과

유형별로는 동맥-정맥 장치 부문이 2033년까지 시장을 장악할 것으로 예상됩니다.

구성 요소별로는 산소 공급기가 예측 기간 동안 주요 부문으로 부상할 것으로 예상됩니다.

용도별로는 성인용 부문이 향후 몇 년동안 두드러진 CAGR을 보일 것으로 예상됩니다.

지역별로는 북미가 2023년 주요 수익 기여 국가로 예측 기간 동안 시장을 장악할 가능성이 높습니다.

본 보고서의 커스터마이징 가능성(추가 비용 및 일정이 필요합니다.)

• 규제 가이드라인
• 고객의 관심사에 따른 기업 프로파일 추가
• 국가별 또는 지역별 추가 분석 - 시장 규모 및 전망
• 기업 프로파일 확장 목록
• 과거 시장 데이터
• SWOT 분석

목차

제1장 서론

제2장 주요 요약

제3장 시장 구도

• 시장 정의와 범위
• 주요 조사 결과
  • 주요 투자 기회
  • 주요 성공 전략
• Porter의 Five Forces 분석
• 시장 역학
  • 성장 촉진요인
  • 성장 억제요인
  • 기회

제4장 체외막산소공급(ECMO) 기계 시장 : 유형별

• 시장 개요
• 동맥
• 정맥
• 기타

제5장 체외식 산소 공급 장비(ECMO) 시장 : 컴포넌트별

• 시장 개요
• 펌프
• 산소 공급기
• 컨트롤러
• 기타

제6장 체외식 산소 공급 장비(ECMO) 시장 : 용도별

• 시장 개요
• 성인
• 소아
• 신생아

제7장 체외식막산소화 장비(ECMO) 시장 : 지역별

• 시장 개요
• 북미
  • 주요 시장 동향과 기회
  • 미국 체외식막산소화 장비(ECMO) 시장
  • 캐나다 체외식막산소화 장비(ECMO) 시장
  • 체외식막산소화 장비(ECMO) 멕시코 시장
• 유럽
  • 주요 시장 동향과 기회
  • 프랑스 체외식막산소화 장비(ECMO) 시장
  • 독일 체외식막산소화 장비(ECMO) 시장
  • 이탈리아 체외식막산소화 장비(ECMO) 시장
  • 스페인 체외식막산소화 장비(ECMO) 시장
  • 영국 체외식막산소화 장비(ECMO) 시장
  • 기타 유럽 체외식막산소화 장비(ECMO) 시장
• 아시아태평양
  • 주요 시장 동향과 기회
  • 중국 체외식막산소화 장비(ECMO) 시장
  • 일본 체외식막산소화 장비(ECMO) 시장
  • 체외식막산소화 장비(ECMO) 인도 시장
  • 한국 체외식막산소화 장비(ECMO) 시장
  • 호주 체외식막산소화 장비(ECMO) 시장
  • 기타 아시아태평양 체외식막산소화 장비(ECMO) 시장
• 라틴아메리카/중동 및 아프리카
  • 주요 시장 동향과 기회
  • 체외식막산소화 장비(ECMO) 브라질 시장
  • 남아프리카공화국 체외식막산소화 장비(ECMO) 시장
  • 사우디아라비아 체외식막산소화 장비(ECMO) 시장
  • 기타 라틴아메리카/중동 및 아프리카 체외식막산소화 장비(ECMO) 시장

제8장 경쟁 구도

• 서론
• 주요 성공 전략
• 주요 10개 기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2023년)

제9장 기업 개요

• Medtronic Plc
• Sorin Group
• Terumo Corporation
• MAQUET Holding
• Nipro Medical Corporation
• Microport Scientific Corporation
• Medos Medizintechnik AG
• GETINGE AB
• Livanova Plc
• Fresnius Medical Care

LSH

영문 목차

영문목차

The extracorporeal membrane oxygenation machine (ECMO) market was valued at $504.2 million in 2023, and is projected to reach $793.7 million by 2033, growing at a CAGR of 4.6% from 2024 to 2033.

Extracorporeal membrane oxygenation machine (ECMO) is a medical device that assists in removal of carbon dioxide and sends oxygen-rich blood back to the body. The machine serves as a life support system to treat individuals suffering from cardiac and pulmonary dysfunction. ECMO functions by circulating blood through an artificial lung (membrane oxygenator) and back into the bloodstream. This process allows the blood to be oxygenated and carbon dioxide to be removed, effectively mimicking the functions of human lungs and heart.

The growth of the global extracorporeal membrane oxygenation machine (ECMO) market is majorly driven by alarming rise in prevalence of respiratory and cardiac diseases such as heart failure and cardiogenic shock. According to the estimates of the Office of National Statistics, UK, approximately 6.6 million individuals were suffering from either a cardiovascular or respiratory condition. Among these, 3.5 million individuals were reported to have a cardiovascular condition, whereas 3.7 million had a respiratory condition. Moreover, increase in awareness among healthcare providers and advancements in medical training lead have led to a wider adoption of ECMO. Based on the June 2023 assessment by the Extracorporeal Life Support Organization (ELSO) registry, ECMO was used on 151,683 patients in 2020. Among these, 75,735 were adults, 30,743 were children, and 45,205 were neonates. Furthermore, surge in geriatric population notably contributes toward the market growth. . This is attributed to the fact that aged individuals are highly susceptible to chronic diseases and organ failure due to functional impairment that limit the ability to carry out day-to-day chores, thus boosting the demand for ECMO. As per the World Health Organization, the number of people aged 60 years and older was 1 billion in 2019. This number is estimated to increase to 1.4 billion by 2030 and 2.1 billion by 2050, which is likely to significantly contribute toward the market growth. However, initial investment and maintenance costs of ECMO systems and dearth of skilled personnel to operate the system hamper the growth of the market. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access act as the key deterrent factors of the market. On the contrary, continuous improvements in ECMO technology, including more compact and efficient systems, and increase in government funding and support to set up & develop critical care infrastructure are expected to offer lucrative opportunities for the expansion of the market during the forecast period.

The extracorporeal membrane oxygenation machine (ECMO) market is segmented into type, component, application, and region. Depending on type, the market is classified into veno-arterial, veno-venous, and arterio-venous. As per component, it is classified into pumps, oxygenator, controllers, and others. On the basis of application, it is segregated into adult, pediatric, and neonates. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Key Findings

By type, the arterio-venous machine segment is expected to dominate the market by 2033.

On the basis of component, oxygenator is anticipated to emerge as a leading segment during the forecast period.

Depending on application, the adult segment is projected to exhibit notable CAGR in the coming years.

Region wise, North America was the major revenue contributor in 2023, and is likely to dominate the market during the forecast period.

Competition Analysis

Competitive analysis and profiles of the major players in the global extracorporeal membrane oxygenation machine (ECMO) market include Medtronic Plc, Sorin Group, Terumo Corporation, MAQUET Holding, Nipro Medical Corporation, Microport Scientific Corporation, Medos Medizintechnik AG, GETINGE AB, Livanova Plc., and Fresnius Medical Care. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to gain a strong foothold in the competitive market.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Expanded list for Company Profiles
• Historic market data
• SWOT Analysis

Key Market Segments

By Type

• Veno-arterial
• Veno-venous
• Others

By Components

• Pumps
• Oxygenator
• Controllers
• Others

By Application

• Adult
• Pediatric
• Neonates

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • France
  • Germany
  • Italy
  • Spain
  • UK
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • South Africa
  • Saudi Arabia
  • Rest of LAMEA

Key Market Players:

• Medtronic Plc
• Sorin Group
• Terumo Corporation
• MAQUET Holding
• Nipro Medical Corporation
• Microport Scientific Corporation
• Medos Medizintechnik AG
• GETINGE AB
• Livanova Plc
• Fresnius Medical Care

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report Description
• 1.2. Key Market Segments
• 1.3. Key Benefits
• 1.4. Research Methodology
  • 1.4.1. Primary Research
  • 1.4.2. Secondary Research
  • 1.4.3. Analyst Tools and Models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET LANDSCAPE

• 3.1. Market Definition and Scope
• 3.2. Key Findings
  • 3.2.1. Top Investment Pockets
  • 3.2.2. Top Winning Strategies
• 3.3. Porter's Five Forces Analysis
  • 3.3.1. Bargaining Power of Suppliers
  • 3.3.2. Threat of New Entrants
  • 3.3.3. Threat of Substitutes
  • 3.3.4. Competitive Rivalry
  • 3.3.5. Bargaining Power among Buyers
• 3.4. Market Dynamics
  • 3.4.1. Drivers
  • 3.4.2. Restraints
  • 3.4.3. Opportunities

CHAPTER 4: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY TYPE

• 4.1. Market Overview
  • 4.1.1 Market Size and Forecast, By Type
• 4.2. Veno-arterial
  • 4.2.1. Key Market Trends, Growth Factors and Opportunities
  • 4.2.2. Market Size and Forecast, By Region
  • 4.2.3. Market Share Analysis, By Country
• 4.3. Veno-venous
  • 4.3.1. Key Market Trends, Growth Factors and Opportunities
  • 4.3.2. Market Size and Forecast, By Region
  • 4.3.3. Market Share Analysis, By Country
• 4.4. Others
  • 4.4.1. Key Market Trends, Growth Factors and Opportunities
  • 4.4.2. Market Size and Forecast, By Region
  • 4.4.3. Market Share Analysis, By Country

CHAPTER 5: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY COMPONENTS

• 5.1. Market Overview
  • 5.1.1 Market Size and Forecast, By Components
• 5.2. Pumps
  • 5.2.1. Key Market Trends, Growth Factors and Opportunities
  • 5.2.2. Market Size and Forecast, By Region
  • 5.2.3. Market Share Analysis, By Country
• 5.3. Oxygenator
  • 5.3.1. Key Market Trends, Growth Factors and Opportunities
  • 5.3.2. Market Size and Forecast, By Region
  • 5.3.3. Market Share Analysis, By Country
• 5.4. Controllers
  • 5.4.1. Key Market Trends, Growth Factors and Opportunities
  • 5.4.2. Market Size and Forecast, By Region
  • 5.4.3. Market Share Analysis, By Country
• 5.5. Others
  • 5.5.1. Key Market Trends, Growth Factors and Opportunities
  • 5.5.2. Market Size and Forecast, By Region
  • 5.5.3. Market Share Analysis, By Country

CHAPTER 6: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY APPLICATION

• 6.1. Market Overview
  • 6.1.1 Market Size and Forecast, By Application
• 6.2. Adult
  • 6.2.1. Key Market Trends, Growth Factors and Opportunities
  • 6.2.2. Market Size and Forecast, By Region
  • 6.2.3. Market Share Analysis, By Country
• 6.3. Pediatric
  • 6.3.1. Key Market Trends, Growth Factors and Opportunities
  • 6.3.2. Market Size and Forecast, By Region
  • 6.3.3. Market Share Analysis, By Country
• 6.4. Neonates
  • 6.4.1. Key Market Trends, Growth Factors and Opportunities
  • 6.4.2. Market Size and Forecast, By Region
  • 6.4.3. Market Share Analysis, By Country

CHAPTER 7: EXTRACORPOREAL MEMBRANE OXYGENATION MACHINE (ECMO) MARKET, BY REGION

• 7.1. Market Overview
  • 7.1.1 Market Size and Forecast, By Region
• 7.2. North America
  • 7.2.1. Key Market Trends and Opportunities
  • 7.2.2. Market Size and Forecast, By Type
  • 7.2.3. Market Size and Forecast, By Components
  • 7.2.4. Market Size and Forecast, By Application
  • 7.2.5. Market Size and Forecast, By Country
  • 7.2.6. U.S. Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.2.6.1. Market Size and Forecast, By Type
    • 7.2.6.2. Market Size and Forecast, By Components
    • 7.2.6.3. Market Size and Forecast, By Application
  • 7.2.7. Canada Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.2.7.1. Market Size and Forecast, By Type
    • 7.2.7.2. Market Size and Forecast, By Components
    • 7.2.7.3. Market Size and Forecast, By Application
  • 7.2.8. Mexico Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.2.8.1. Market Size and Forecast, By Type
    • 7.2.8.2. Market Size and Forecast, By Components
    • 7.2.8.3. Market Size and Forecast, By Application
• 7.3. Europe
  • 7.3.1. Key Market Trends and Opportunities
  • 7.3.2. Market Size and Forecast, By Type
  • 7.3.3. Market Size and Forecast, By Components
  • 7.3.4. Market Size and Forecast, By Application
  • 7.3.5. Market Size and Forecast, By Country
  • 7.3.6. France Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.6.1. Market Size and Forecast, By Type
    • 7.3.6.2. Market Size and Forecast, By Components
    • 7.3.6.3. Market Size and Forecast, By Application
  • 7.3.7. Germany Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.7.1. Market Size and Forecast, By Type
    • 7.3.7.2. Market Size and Forecast, By Components
    • 7.3.7.3. Market Size and Forecast, By Application
  • 7.3.8. Italy Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.8.1. Market Size and Forecast, By Type
    • 7.3.8.2. Market Size and Forecast, By Components
    • 7.3.8.3. Market Size and Forecast, By Application
  • 7.3.9. Spain Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.9.1. Market Size and Forecast, By Type
    • 7.3.9.2. Market Size and Forecast, By Components
    • 7.3.9.3. Market Size and Forecast, By Application
  • 7.3.10. UK Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.10.1. Market Size and Forecast, By Type
    • 7.3.10.2. Market Size and Forecast, By Components
    • 7.3.10.3. Market Size and Forecast, By Application
  • 7.3.11. Rest of Europe Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.3.11.1. Market Size and Forecast, By Type
    • 7.3.11.2. Market Size and Forecast, By Components
    • 7.3.11.3. Market Size and Forecast, By Application
• 7.4. Asia-Pacific
  • 7.4.1. Key Market Trends and Opportunities
  • 7.4.2. Market Size and Forecast, By Type
  • 7.4.3. Market Size and Forecast, By Components
  • 7.4.4. Market Size and Forecast, By Application
  • 7.4.5. Market Size and Forecast, By Country
  • 7.4.6. China Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.6.1. Market Size and Forecast, By Type
    • 7.4.6.2. Market Size and Forecast, By Components
    • 7.4.6.3. Market Size and Forecast, By Application
  • 7.4.7. Japan Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.7.1. Market Size and Forecast, By Type
    • 7.4.7.2. Market Size and Forecast, By Components
    • 7.4.7.3. Market Size and Forecast, By Application
  • 7.4.8. India Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.8.1. Market Size and Forecast, By Type
    • 7.4.8.2. Market Size and Forecast, By Components
    • 7.4.8.3. Market Size and Forecast, By Application
  • 7.4.9. South Korea Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.9.1. Market Size and Forecast, By Type
    • 7.4.9.2. Market Size and Forecast, By Components
    • 7.4.9.3. Market Size and Forecast, By Application
  • 7.4.10. Australia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.10.1. Market Size and Forecast, By Type
    • 7.4.10.2. Market Size and Forecast, By Components
    • 7.4.10.3. Market Size and Forecast, By Application
  • 7.4.11. Rest of Asia-Pacific Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.4.11.1. Market Size and Forecast, By Type
    • 7.4.11.2. Market Size and Forecast, By Components
    • 7.4.11.3. Market Size and Forecast, By Application
• 7.5. LAMEA
  • 7.5.1. Key Market Trends and Opportunities
  • 7.5.2. Market Size and Forecast, By Type
  • 7.5.3. Market Size and Forecast, By Components
  • 7.5.4. Market Size and Forecast, By Application
  • 7.5.5. Market Size and Forecast, By Country
  • 7.5.6. Brazil Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.5.6.1. Market Size and Forecast, By Type
    • 7.5.6.2. Market Size and Forecast, By Components
    • 7.5.6.3. Market Size and Forecast, By Application
  • 7.5.7. South Africa Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.5.7.1. Market Size and Forecast, By Type
    • 7.5.7.2. Market Size and Forecast, By Components
    • 7.5.7.3. Market Size and Forecast, By Application
  • 7.5.8. Saudi Arabia Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.5.8.1. Market Size and Forecast, By Type
    • 7.5.8.2. Market Size and Forecast, By Components
    • 7.5.8.3. Market Size and Forecast, By Application
  • 7.5.9. Rest of LAMEA Extracorporeal Membrane Oxygenation Machine (ECMO) Market
    • 7.5.9.1. Market Size and Forecast, By Type
    • 7.5.9.2. Market Size and Forecast, By Components
    • 7.5.9.3. Market Size and Forecast, By Application

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top Winning Strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top Player Positioning, 2023

CHAPTER 9: COMPANY PROFILES

• 9.1. Medtronic Plc
  • 9.1.1. Company Overview
  • 9.1.2. Key Executives
  • 9.1.3. Company Snapshot
  • 9.1.4. Operating Business Segments
  • 9.1.5. Product Portfolio
  • 9.1.6. Business Performance
  • 9.1.7. Key Strategic Moves and Developments
• 9.2. Sorin Group
  • 9.2.1. Company Overview
  • 9.2.2. Key Executives
  • 9.2.3. Company Snapshot
  • 9.2.4. Operating Business Segments
  • 9.2.5. Product Portfolio
  • 9.2.6. Business Performance
  • 9.2.7. Key Strategic Moves and Developments
• 9.3. Terumo Corporation
  • 9.3.1. Company Overview
  • 9.3.2. Key Executives
  • 9.3.3. Company Snapshot
  • 9.3.4. Operating Business Segments
  • 9.3.5. Product Portfolio
  • 9.3.6. Business Performance
  • 9.3.7. Key Strategic Moves and Developments
• 9.4. MAQUET Holding
  • 9.4.1. Company Overview
  • 9.4.2. Key Executives
  • 9.4.3. Company Snapshot
  • 9.4.4. Operating Business Segments
  • 9.4.5. Product Portfolio
  • 9.4.6. Business Performance
  • 9.4.7. Key Strategic Moves and Developments
• 9.5. Nipro Medical Corporation
  • 9.5.1. Company Overview
  • 9.5.2. Key Executives
  • 9.5.3. Company Snapshot
  • 9.5.4. Operating Business Segments
  • 9.5.5. Product Portfolio
  • 9.5.6. Business Performance
  • 9.5.7. Key Strategic Moves and Developments
• 9.6. Microport Scientific Corporation
  • 9.6.1. Company Overview
  • 9.6.2. Key Executives
  • 9.6.3. Company Snapshot
  • 9.6.4. Operating Business Segments
  • 9.6.5. Product Portfolio
  • 9.6.6. Business Performance
  • 9.6.7. Key Strategic Moves and Developments
• 9.7. Medos Medizintechnik AG
  • 9.7.1. Company Overview
  • 9.7.2. Key Executives
  • 9.7.3. Company Snapshot
  • 9.7.4. Operating Business Segments
  • 9.7.5. Product Portfolio
  • 9.7.6. Business Performance
  • 9.7.7. Key Strategic Moves and Developments
• 9.8. GETINGE AB
  • 9.8.1. Company Overview
  • 9.8.2. Key Executives
  • 9.8.3. Company Snapshot
  • 9.8.4. Operating Business Segments
  • 9.8.5. Product Portfolio
  • 9.8.6. Business Performance
  • 9.8.7. Key Strategic Moves and Developments
• 9.9. Livanova Plc
  • 9.9.1. Company Overview
  • 9.9.2. Key Executives
  • 9.9.3. Company Snapshot
  • 9.9.4. Operating Business Segments
  • 9.9.5. Product Portfolio
  • 9.9.6. Business Performance
  • 9.9.7. Key Strategic Moves and Developments
• 9.10. Fresnius Medical Care
  • 9.10.1. Company Overview
  • 9.10.2. Key Executives
  • 9.10.3. Company Snapshot
  • 9.10.4. Operating Business Segments
  • 9.10.5. Product Portfolio
  • 9.10.6. Business Performance
  • 9.10.7. Key Strategic Moves and Developments

관련자료